NovoCure

Novocure is a private oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland and Japan and a research center in Haifa, Israel

Novocure is an overnight success story fourteen years in the making. Since 2000, the company has grown from one inspired man running experiments in his basement lab to the multinational commercial business it is today.
Type
Public
HQ
Saint Helier, JE
Founded
2000
Employees
318 (est)+64%

Key People at NovoCure

David N.

David N.

General Manager Europe
Moshe Giladi

Moshe Giladi

Head of preclinical research
Bill Burke

Bill Burke

Global Head HR
Laura Benson

Laura Benson

Vice President Medical Affairs

NovoCure Locations

Saint Helier, JE
Root, CH
Portsmouth, US
Haifa, IL
Haifa, IL
Atlanta, US
Tacoma, US
Phoenix, US
Chicago, US
Los Angeles, US
Philadelphia, US
Boston, US
San Diego, US
Raleigh, US
Portland, US
New York, US
Malvern, US
Jacksonville, US
Pittsburgh, US
Oklahoma City, US

NovoCure Metrics

NovoCure Summary

Founding Date

2000

Market capitalization

$694 M

Closing share price

$7.45

NovoCure Market Value History

NovoCure Company Life

You may also be interested in